Overview

Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects

Status:
Withdrawn

Trial end date:
2013-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and efficacy of product 0405 in pediatric subjects with Mild to Moderate Atopic Dermatitis.

Phase:

Phase 3

Details

Lead Sponsor:

Fougera Pharmaceuticals Inc.